Prezista (Darunavir, TMC114)
We asked HIV specialist Cal Cohen, M.D., to discuss Prezista not long after it was approved.
He summarizes the essentials about this drug, including side effects and the ideal way to use this drug.
Listen
(18 min.)
Read transcript
Prezista, also known as darunavir or TMC114, is a type of medicine called a protease inhibitor (PI). PIs work by blocking protease, a protein that HV needs to make more copies of itself. Read More >>
- Should Prezista Be Used as a First-Line Treatment?
- Is Prezista "Bulletproof"?
- Am I Already Resistant to Prezista and Intelence?
- Are Fuzeon and Prezista Really My Only Options?
- 48-Week Prezista + Norvir Data Set New Bar for Efficacy in Triple-Class-Experienced Patients
At 48 weeks, a twice-daily dose of Prezista + Norvir continues to yield a viral load and CD4+ cell response that is superior to comparator protease inhibitors in triple-class-experienced patients. Graeme Moyle, M.D., reports on the latest data from the POWER studies Read More >>
We asked HIV specialist Cal Cohen, M.D., to discuss Prezista not long after it was approved.
He summarizes the essentials about this drug, including side effects and the ideal way to use this drug.Listen
(18 min.)Read transcript
 | ||
| Brand Name: |
Prezista |
|
| Generic Name: |
Darunavir, TMC114 |
|
| Adult Single Dose: |
Two 300 mg tablets twice daily taken with Norvir 100 mg twice daily |
|
| Food & Liquid Restrictions: |
Take with food |
|
| Drug Class: |
Protease inhibitor |
|
| Patient Information About Prezista >> | ||
 | ||
 | ||
| ||